159 related articles for article (PubMed ID: 30140699)
1. Effective Treatment of Chronic Proliferative Cholangitis by Local Gentamicin Infusion in Rabbits.
Yang Q; Wu Z; Liu F; Wang J; Ma W; Hu H; Li F; Pan Q
Biomed Res Int; 2018; 2018():6751952. PubMed ID: 30140699
[TBL] [Abstract][Full Text] [Related]
2. Biliary antibiotics irrigation for E. coli-induced chronic proliferative cholangitis and hepatolithiasis: A pathophysiological study in rabbits.
Ma WJ; Wu ZR; Yang Q; Hu HJ; Wang JK; Shi YJ; Li FY; Cheng NS
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):356-367. PubMed ID: 31420296
[TBL] [Abstract][Full Text] [Related]
3. Significance of controlling chronic proliferative cholangitis in the treatment of hepatolithiasis.
Li FY; Cheng NS; Mao H; Jiang LS; Cheng JQ; Li QS; Munireddy S
World J Surg; 2009 Oct; 33(10):2155-60. PubMed ID: 19641953
[TBL] [Abstract][Full Text] [Related]
4. Effects of epidermal growth factor receptor inhibitor on proliferative cholangitis in hepatolithiasis.
Yang Q; Zhou Y; Li FY; Mao H; Shrestha A; Ma WJ; Cheng NS; Zhang W
Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):509-15. PubMed ID: 26459727
[TBL] [Abstract][Full Text] [Related]
5. EGFR monoclonal antibody panitumumab inhibits chronic proliferative cholangitis by downregulating EGFR.
Liu SH; Chen XF; Xie ZB; Zhou J
Int J Mol Med; 2019 Jul; 44(1):79-88. PubMed ID: 31115490
[TBL] [Abstract][Full Text] [Related]
6. Bacteriology of hepatolithiasis.
Tabata M; Nakayama F
Prog Clin Biol Res; 1984; 152():163-74. PubMed ID: 6382275
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen shRNA treatment attenuates chronic proliferative cholangitis in rats.
Li FY; Cheng NS; Cheng JQ; Mao H; Zhou Y; Jiang LS; Li N
J Gastroenterol Hepatol; 2009 May; 24(5):920-6. PubMed ID: 19032457
[TBL] [Abstract][Full Text] [Related]
8. The practical value of applying chemical biliary duct embolization to chemical hepatectomy for treatment of hepatolithiasis.
Li F; Cheng J; He S; Li N; Zhang M; Dong J; Jiang L; Cheng N; Xiong X
J Surg Res; 2005 Aug; 127(2):131-8. PubMed ID: 15936771
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic proliferative cholangitis with c-myc shRNA.
Li FY; Cheng NS; Cheng JQ; Mao H; Jiang LS; Li N; He S
World J Gastroenterol; 2009 Jan; 15(1):95-101. PubMed ID: 19115473
[TBL] [Abstract][Full Text] [Related]
10. Bacteriology and antimicrobial choice in hepatolithiasis.
Sheen-Chen S; Chen W; Eng H; Sheen C; Chou F; Cheng Y; Lee T
Am J Infect Control; 2000 Aug; 28(4):298-301. PubMed ID: 10926707
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen expression in peribiliary glands of stone-containing intrahepatic bile ducts.
Lee KT; Sheen PC
Dig Dis Sci; 1999 Nov; 44(11):2251-6. PubMed ID: 10573370
[TBL] [Abstract][Full Text] [Related]
12. [Intrahepatic biliary gland proliferation its relation to acute and chronic cholangitis in hepatolithiasis].
Chen YL
Zhonghua Wai Ke Za Zhi; 1993 Jan; 31(1):37-9. PubMed ID: 8404341
[TBL] [Abstract][Full Text] [Related]
13. The distribution of secretory immunoglobulin A in the intrahepatic biliary epithelium of patients with hepatolithiasis.
Hamba H; Kinoshita H; Hirohashi K; Kubo S; Fujio N
Surg Today; 1994; 24(9):849-51. PubMed ID: 7865966
[TBL] [Abstract][Full Text] [Related]
14. Applying chemical bile duct embolization to achieve chemical hepatectomy in hepatolithiasis: a further experimental study.
Ma WJ; Zhou Y; Shrestha A; Mao H; Li FY; Cheng NS; Zhang W; Xu RH; Zhang YQ; Jiang T; Feng H; Li W; Han Q
J Surg Res; 2014 Mar; 187(1):113-21. PubMed ID: 24290428
[TBL] [Abstract][Full Text] [Related]
15. Suppression of proliferative cholangitis in a rat model by local delivery of paclitaxel.
Park SM; Choi JW; Kim ST; Cho MC; Sung RH; Jang LC; Park JW; Lee SP; Park YH
J Hepatobiliary Pancreat Surg; 2003; 10(2):176-82. PubMed ID: 14505153
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of percutaneous transhepatic cholangioscopic lithotomy for hepatolithiasis.
Huang MH; Chen CH; Yang JC; Yang CC; Yeh YH; Chou DA; Mo LR; Yueh SK; Nien CK
Am J Gastroenterol; 2003 Dec; 98(12):2655-62. PubMed ID: 14687812
[TBL] [Abstract][Full Text] [Related]
17. The effect of decreased portal blood flow on the biliary system.
Saji Y
Jpn J Surg; 1988 Sep; 18(5):558-68. PubMed ID: 3230727
[TBL] [Abstract][Full Text] [Related]
18. Peptide antibiotic human beta-defensin-1 and -2 contribute to antimicrobial defense of the intrahepatic biliary tree.
Harada K; Ohba K; Ozaki S; Isse K; Hirayama T; Wada A; Nakanuma Y
Hepatology; 2004 Oct; 40(4):925-32. PubMed ID: 15382127
[TBL] [Abstract][Full Text] [Related]
19. Expression of alpha-amylase isoenzymes and trypsin by the proliferating epithelium of large intrahepatic bile ducts and intrahepatic peribiliary glands in hepatolithiasis.
Terada T; Nakanuma Y
Histopathology; 1993 May; 22(5):467-73. PubMed ID: 8344656
[TBL] [Abstract][Full Text] [Related]
20. Expression of deleted in malignant brain tumor-1 (DMBT1) molecule in biliary epithelium is augmented in hepatolithiasis: possible participation in lithogenesis.
Sasaki M; Huang SF; Chen MF; Jan YY; Yeh TS; Ishikawa A; Mollenhauer J; Poustka A; Tsuneyama K; Nimura Y; Oda K; Nakanuma Y
Dig Dis Sci; 2003 Jul; 48(7):1234-40. PubMed ID: 12870778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
